Nathalie Charland

1.5k total citations
25 papers, 1.0k citations indexed

About

Nathalie Charland is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Nathalie Charland has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Public Health, Environmental and Occupational Health and 8 papers in Infectious Diseases. Recurrent topics in Nathalie Charland's work include Streptococcal Infections and Treatments (10 papers), Transgenic Plants and Applications (8 papers) and Influenza Virus Research Studies (7 papers). Nathalie Charland is often cited by papers focused on Streptococcal Infections and Treatments (10 papers), Transgenic Plants and Applications (8 papers) and Influenza Virus Research Studies (7 papers). Nathalie Charland collaborates with scholars based in Canada, United States and France. Nathalie Charland's co-authors include Marcelo Gottschalk, Nathalie Landry, Sonia Trépanier, Marc‐André D’Aoust, Louis‐P. Vézina, Manon Couture, Marylène Kobisch, Sonia Lacouture, Josée Harel and Denis Martin and has published in prestigious journals such as Nature Communications, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Nathalie Charland

25 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathalie Charland Canada 14 420 366 288 265 235 25 1.0k
Tiziana Maggi Italy 13 437 1.0× 281 0.8× 360 1.3× 494 1.9× 86 0.4× 17 1.1k
Stephen B. Olmsted United States 20 478 1.1× 230 0.6× 504 1.8× 361 1.4× 47 0.2× 25 1.3k
Jon H. Heinrichs United States 17 220 0.5× 529 1.4× 704 2.4× 718 2.7× 76 0.3× 36 1.5k
Nancy Twenhafel United States 20 178 0.4× 383 1.0× 522 1.8× 590 2.2× 81 0.3× 39 1.3k
Robert L. Cole United States 17 386 0.9× 199 0.5× 538 1.9× 398 1.5× 37 0.2× 22 1.3k
Christian Savard Canada 17 107 0.3× 239 0.7× 159 0.6× 247 0.9× 132 0.6× 31 869
Ying Ma China 18 333 0.8× 200 0.5× 413 1.4× 220 0.8× 24 0.1× 78 1.0k
J L Michel United States 17 660 1.6× 394 1.1× 292 1.0× 162 0.6× 42 0.2× 20 1.0k
Valerian Nakaar United States 14 147 0.3× 713 1.9× 215 0.7× 379 1.4× 47 0.2× 21 1.3k
Esperanza Gómez‐Lucía Spain 20 58 0.1× 364 1.0× 338 1.2× 238 0.9× 243 1.0× 87 1.3k

Countries citing papers authored by Nathalie Charland

Since Specialization
Citations

This map shows the geographic impact of Nathalie Charland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Charland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Charland more than expected).

Fields of papers citing papers by Nathalie Charland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Charland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Charland. The network helps show where Nathalie Charland may publish in the future.

Co-authorship network of co-authors of Nathalie Charland

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Charland. A scholar is included among the top collaborators of Nathalie Charland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Charland. Nathalie Charland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kapłonek, Paulina, Deniz Cizmeci, Sally Shin, et al.. (2023). Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19. npj Vaccines. 8(1). 13–13. 4 indexed citations
2.
Alvarez, Fernando, Roman Istomine, Stéphane Pillet, et al.. (2022). A Hemagglutinin 1 Carrying Plant-Based Virus-like Particle Vaccine Generates an Efficacious Cellular Response by Exploiting IL-1 Signaling in Both Adult and Aged Mice. ImmunoHorizons. 6(6). 384–397. 4 indexed citations
3.
Gobeil, Philipe, Stéphane Pillet, Iohann Boulay, et al.. (2022). Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19. Nature Communications. 13(1). 6905–6905. 7 indexed citations
4.
Charland, Nathalie, et al.. (2021). Projected impact of a plant-derived vaccine on the burden of seasonal influenza in Canada. Human Vaccines & Immunotherapeutics. 17(10). 3643–3651. 1 indexed citations
5.
Макарков, А. И., Makan Golizeh, Sabrina Chierzi, et al.. (2019). Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages. npj Vaccines. 4(1). 17–17. 24 indexed citations
6.
Carter, Darrick, Neal Van Hoeven, Susan L. Baldwin, et al.. (2018). The adjuvant GLA-AF enhances human intradermal vaccine responses. Science Advances. 4(9). eaas9930–eaas9930. 33 indexed citations
7.
Guak, Hannah, et al.. (2018). Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin. Vaccine. 36(52). 8028–8038. 13 indexed citations
8.
Champredon, David, Marek Laskowski, Nathalie Charland, & Seyed M. Moghadas. (2018). Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada. Scientific Reports. 8(1). 6492–6492. 2 indexed citations
9.
Ward, Brian J., et al.. (2017). The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?. Human Vaccines & Immunotherapeutics. 14(3). 647–656. 43 indexed citations
10.
11.
Xiao, Yanyu, et al.. (2015). Strategies for Early Vaccination During Novel Influenza Outbreaks. Scientific Reports. 5(1). 18062–18062. 6 indexed citations
12.
Charland, Nathalie. (2012). Plant-Made Influenza Virus-Like Particles: for Pandemic and Beyond. 1 indexed citations
13.
D’Aoust, Marc‐André, Manon Couture, Nathalie Charland, et al.. (2010). The production of hemagglutinin‐based virus‐like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnology Journal. 8(5). 607–619. 268 indexed citations
14.
Hamel, Josée, Nathalie Charland, Isabelle Pineau, et al.. (2004). Prevention of Pneumococcal Disease in Mice Immunized with Conserved Surface-Accessible Proteins. Infection and Immunity. 72(5). 2659–2670. 70 indexed citations
15.
Charland, Nathalie, Victor Nizet, Craig E. Rubens, et al.. (2000). Streptococcus suis Serotype 2 Interactions with Human Brain Microvascular Endothelial Cells. Infection and Immunity. 68(2). 637–643. 115 indexed citations
16.
Charland, Nathalie, Mario Jacques, Sonia Lacouture, & Marcelo Gottschalk. (1997). Characterization and protective activity of a monoclonal antibody against a capsular epitope shared by Streptococcus suis serotypes 1, 2 and 1/2. Microbiology. 143(11). 3607–3614. 37 indexed citations
17.
Charland, Nathalie, Marylène Kobisch, B. Martineau‐Doizé, Mario Jacques, & Marcelo Gottschalk. (1996). Role of capsular sialic acid in virulence and resistance to phagocytosis ofStreptococcus suiscapsular type 2. FEMS Immunology & Medical Microbiology. 14(4). 195–203. 52 indexed citations
18.
Charland, Nathalie. (1996). Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2. FEMS Immunology & Medical Microbiology. 14(4). 195–203. 5 indexed citations
19.
Charland, Nathalie, et al.. (1995). Contact-dependent acquisition of transferrin-bound iron by two strains of Haemophilus parasuis. Canadian Journal of Microbiology. 41(1). 70–74. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tiziana Maggi Breakdown of academic impact, for papers by Stephen B. Olmsted Breakdown of academic impact, for papers by Jon H. Heinrichs Breakdown of academic impact, for papers by Nancy Twenhafel Breakdown of academic impact, for papers by Robert L. Cole Breakdown of academic impact, for papers by Christian Savard Breakdown of academic impact, for papers by Ying Ma Breakdown of academic impact, for papers by J L Michel Breakdown of academic impact, for papers by Valerian Nakaar Breakdown of academic impact, for papers by Esperanza Gómez‐Lucía
Rankless by CCL
2026